产品详情
In vitro (25°C) | DMSO | 70 mg/mL (172.66 mM) | |
Water | Insoluble | ||
Ethanol | 70 mg/mL (172.66 mM) | ||
In vivo | 30% propylene glycol, 5% Tween 80, 65% D5W | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.67 mL | 123.33 mL | 246.67 mL |
0.5 mM | 4.93 mL | 24.67 mL | 49.33 mL |
1 mM | 2.47 mL | 12.33 mL | 24.67 mL |
5 mM | 0.49 mL | 2.47 mL | 4.93 mL |
*The above data is based on the productmolecular weight 405.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10838 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 405.4 |
Formula | C20H22F3N5O |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1025065-69-3 |
Synonyms | SGI1776 |
SMILES | CN1CCC(CC1)CNC2=NN3C(=NC=C3C4=CC(=CC=C4)OC(F)(F)F)C=C2 |
产品资料
产品标签
Product Questions
Product Questions
Cyt387 (Momelotinib)
Cyt387 (Momelotinib)是Janus激酶JAK1和JAK2的抑制剂,可作为ATP竞争者,IC50值分别为11和18 nM。
Pexidartinib (PLX3397)
Pexidartinib (PLX3397)是KIT,CSF1R和FLT3的小分子酪氨酸激酶(RTK)抑制剂,具有潜在的抗肿瘤活性。
VX-680 (MK-0457, Tozasertib)
VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。
BMS-911543
BMS-911543是一种有效的、选择性JAK2小分子抑制剂。
Filgotinib
Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。